Revvity (RVTY) Following Its Margin Story Is The Stock Already Fully Valued
Revvity (RVTY) is back in focus after a recent upgrade to a Zacks Rank #2, reflecting higher earnings estimates and renewed attention on how its valuation lines up with mixed growth signals.
Revvity’s share price has climbed 25.25% over the past 90 days and 28.98% year to date, while its 1 year total shareholder return of 44.46% contrasts with a weaker 5 year total shareholder return. This suggests that recent momentum has picked up after a tougher longer stretch.
Compare Revvity’s renewed momentum with a curated set of other companies showing similar earnings and price action by scanning the 50 high quality undervalued stocks, which may still be flying under the radar.
The question now is whether Revvity’s sharp rebound reflects a healthier earnings outlook or a swing in sentiment that has run ahead of fundamentals. The answer starts to emerge once you compare that move with valuation.
Most Popular Narrative: 4.6% Overvalued
Revvity’s last close at $126.59 sits modestly above the narrative fair value of $121.07. This frames the recent share price strength against projected cash flows and profitability.
Ongoing shift in product mix toward higher-margin, software-enabled and consumables-driven offerings (e.g., SaaS Signals, reagents, new IDS i20 platform), along with structural cost actions, are expected to materially expand operating and net margins, with 2026 set to start at a higher 28% operating margin baseline.
Want to see what sits behind that higher margin starting point? The narrative focuses on measured revenue growth, faster profit expansion and a future earnings multiple that has been carefully adjusted lower. This combination is what supports that fair value mark for Revvity.
Result: Fair Value of $121.07 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to weigh risks such as weaker academic and government funding, or tighter healthcare pricing that could pressure Revvity’s diagnostics volumes and margins.
Find out about the key risks to this Revvity narrative.
Revvity Valuation Check: DCF Points the Other Way
There is a twist when you look at Revvity through the SWS DCF model. On this view, the stock at $126.59 screens as undervalued compared with an estimated future cash flow value of $135.21. That is very different from the 4.6% overvalued narrative fair value of $121.07.
Both approaches use the same company, but they reward different things. The narrative view leans on earnings, margins and multiples. The DCF view focuses on long term cash generation and the discount rate. Which lens do you think better reflects how you expect Revvity to perform over time?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Revvity for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If this combination of optimism and caution around Revvity leaves you undecided, consider reviewing the data yourself soon, before sentiment shifts further. You can evaluate both sides of the story in one place by checking the 2 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Revvity?
If you are serious about finding the next opportunity before it becomes crowded, use the Simply Wall St Screener to compare Revvity with other stocks on your watchlist.
- Spot potential bargains early by scanning the 50 high quality undervalued stocks that combine quality fundamentals with more modest pricing.
- Secure your income stream by reviewing the 12 dividend fortresses that aim to pair higher yields with resilient payout histories.
- Reduce portfolio shocks by focusing on the 74 resilient stocks with low risk scores that score well on financial strength and business stability.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com